Corconsult Rx: Evidence-based Medicine And Pharmacy

On this episode, we discuss some of the new medications that were FDA approved in the first half of 2024. We discuss pivmecillinam (Pivya), ceftobiprole medocaril sodium (Zevtera), vadadustat (Vafseo), sotatercept (Winrevair), aprocitentan (Tryvio), cefepime/enmetazobactam (Exblifep), and more. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you’re not currently a freeCE member, we definitely suggest you explore all the be